Review



human synapsin1 promoter  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc human synapsin1 promoter
    Human Synapsin1 Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hsyn1+promoter/pAAV%2EhSyn1%2ETwitch2B%2EWPRE%2ESV40+(Plasmid+%23100040)/bio_rxiv__2025__11__24__690198-110-25-29
    Average 93 stars, based on 5 article reviews
    human synapsin1 promoter - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Comparative Ca 2+ channel contributions to intracellular Ca 2+ levels in the circadian clock
    Article Snippet: .. On culture day 3, SCN slices cultured on MEAs were transduced with 0.3 μL of AAV1 containing GCaMP6f cDNA expressed under the hSyn1 promoter (AAV1.Syn1.GCaMP6f.SV40.WPRE; stock 1x1013 vg/mL, Addgene, #100837-AAV1) (Figure S1A) and cultured for an additional 14-21 days. ..

    Transduction:

    Article Title: Comparative Ca 2+ channel contributions to intracellular Ca 2+ levels in the circadian clock
    Article Snippet: .. On culture day 3, SCN slices cultured on MEAs were transduced with 0.3 μL of AAV1 containing GCaMP6f cDNA expressed under the hSyn1 promoter (AAV1.Syn1.GCaMP6f.SV40.WPRE; stock 1x1013 vg/mL, Addgene, #100837-AAV1) (Figure S1A) and cultured for an additional 14-21 days. ..

    Virus:

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Expressing:

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Control:

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Article Title: Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
    Article Snippet: .. In addition to the gRNA virus, one set of cells received a lentivirus expressing the Cre recombinase under the control of the hSyn1 promoter (Addgene 86641). ..

    Construct:

    Article Title: CDK5/p35-Dependent Microtubule Reorganization Contributes to Homeostatic Shortening of the Axon Initial Segment
    Article Snippet: .. All plasmids were constructed by inserting the following sequences into the plasmid backbone of pCAG-floxedSTOP-tdTomato-WPRE (Egawa and Yawo, 2019) using In-Fusion cloning (Takara Bio): hSyn1 promoter (pLenti Syn hChR2-EYFP-Nav1.2II-III; a gift from Matthew S. Grubb; Grubb and Burrone, 2010), TetOn3G and TRE3GS promoter (pTetOne Vector, catalog #634301, Clontech), mGreenLantern (LifeAct-mGreenLantern, plasmid catalog #164459, Addgene; a gift from Gregory Petsko; Campbell et al., 2020), CDK5 and dominant-negative CDK5 (Cdk5-HA and Cdk5DN-HA, plasmid #1872 and #1873, Addgene; a gift from Sander van den Heuvel; van den Heuvel and Harlow, 1993), and p35 (pCMV-P35, plasmid #1347, Addgene; a gift from Li-Huei Tsai). ..

    Article Title: The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
    Article Snippet: .. The following plasmids were obtained from Addgene (Watertown, MA, USA): pAd-deltaF6 (#112867), pUCmini-iCAPPHP.eB (#103005), pAAV2/5 (#104964), pAAV2/9 (#112865), and pAAV-CAG-GFP (#37825). pAAV-hGFAP-GFP was previously described (Wang et al., 2021). pAAV-hSYN1-GFP was made by replacing the hGFAP promoter with the hSYN1 promoter (from Addgene #50457). pAAV-CAG-GFP-CNH, pAAV-CAGBioID2-CNH, pAAV-hGFAP-CNH, and pAAV-hSYN1-CNH were then constructed through PCR-based subcloning into pAAV-CAG-GFP, pAAV-hGFAP-GFP and pAAV-hSYN1-GFP, respectively. ..

    Article Title: The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
    Article Snippet: .. The following plasmids were obtained from Addgene (Watertown, MA, USA): pAd-deltaF6 (#112867), pUCmini-iCAP-PHP.eB (#103005), pAAV2/5 (#104964), pAAV2/9 (#112865), and pAAV-CAG-GFP (#37825). pAAV-hGFAP-GFP was previously described (Wang et al., 2021). pAAV-hSYN1-GFP was made by replacing the hGFAP promoter with the hSYN1 promoter (from Addgene #50457). pAAV-CAG-GFP-CNH , pAAV-CAG-BioID2-CNH , pAAV-hGFAP-CNH , and pAAV-hSYN1-CNH were then constructed through PCR-based subcloning into pAAV-CAG-GFP , pAAV-hGFAP-GFP and pAAV-hSYN1-GFP , respectively. ..

    Plasmid Preparation:

    Article Title: CDK5/p35-Dependent Microtubule Reorganization Contributes to Homeostatic Shortening of the Axon Initial Segment
    Article Snippet: .. All plasmids were constructed by inserting the following sequences into the plasmid backbone of pCAG-floxedSTOP-tdTomato-WPRE (Egawa and Yawo, 2019) using In-Fusion cloning (Takara Bio): hSyn1 promoter (pLenti Syn hChR2-EYFP-Nav1.2II-III; a gift from Matthew S. Grubb; Grubb and Burrone, 2010), TetOn3G and TRE3GS promoter (pTetOne Vector, catalog #634301, Clontech), mGreenLantern (LifeAct-mGreenLantern, plasmid catalog #164459, Addgene; a gift from Gregory Petsko; Campbell et al., 2020), CDK5 and dominant-negative CDK5 (Cdk5-HA and Cdk5DN-HA, plasmid #1872 and #1873, Addgene; a gift from Sander van den Heuvel; van den Heuvel and Harlow, 1993), and p35 (pCMV-P35, plasmid #1347, Addgene; a gift from Li-Huei Tsai). ..

    Cloning:

    Article Title: CDK5/p35-Dependent Microtubule Reorganization Contributes to Homeostatic Shortening of the Axon Initial Segment
    Article Snippet: .. All plasmids were constructed by inserting the following sequences into the plasmid backbone of pCAG-floxedSTOP-tdTomato-WPRE (Egawa and Yawo, 2019) using In-Fusion cloning (Takara Bio): hSyn1 promoter (pLenti Syn hChR2-EYFP-Nav1.2II-III; a gift from Matthew S. Grubb; Grubb and Burrone, 2010), TetOn3G and TRE3GS promoter (pTetOne Vector, catalog #634301, Clontech), mGreenLantern (LifeAct-mGreenLantern, plasmid catalog #164459, Addgene; a gift from Gregory Petsko; Campbell et al., 2020), CDK5 and dominant-negative CDK5 (Cdk5-HA and Cdk5DN-HA, plasmid #1872 and #1873, Addgene; a gift from Sander van den Heuvel; van den Heuvel and Harlow, 1993), and p35 (pCMV-P35, plasmid #1347, Addgene; a gift from Li-Huei Tsai). ..

    Dominant Negative Mutation:

    Article Title: CDK5/p35-Dependent Microtubule Reorganization Contributes to Homeostatic Shortening of the Axon Initial Segment
    Article Snippet: .. All plasmids were constructed by inserting the following sequences into the plasmid backbone of pCAG-floxedSTOP-tdTomato-WPRE (Egawa and Yawo, 2019) using In-Fusion cloning (Takara Bio): hSyn1 promoter (pLenti Syn hChR2-EYFP-Nav1.2II-III; a gift from Matthew S. Grubb; Grubb and Burrone, 2010), TetOn3G and TRE3GS promoter (pTetOne Vector, catalog #634301, Clontech), mGreenLantern (LifeAct-mGreenLantern, plasmid catalog #164459, Addgene; a gift from Gregory Petsko; Campbell et al., 2020), CDK5 and dominant-negative CDK5 (Cdk5-HA and Cdk5DN-HA, plasmid #1872 and #1873, Addgene; a gift from Sander van den Heuvel; van den Heuvel and Harlow, 1993), and p35 (pCMV-P35, plasmid #1347, Addgene; a gift from Li-Huei Tsai). ..

    Polymerase Chain Reaction:

    Article Title: The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
    Article Snippet: .. The following plasmids were obtained from Addgene (Watertown, MA, USA): pAd-deltaF6 (#112867), pUCmini-iCAPPHP.eB (#103005), pAAV2/5 (#104964), pAAV2/9 (#112865), and pAAV-CAG-GFP (#37825). pAAV-hGFAP-GFP was previously described (Wang et al., 2021). pAAV-hSYN1-GFP was made by replacing the hGFAP promoter with the hSYN1 promoter (from Addgene #50457). pAAV-CAG-GFP-CNH, pAAV-CAGBioID2-CNH, pAAV-hGFAP-CNH, and pAAV-hSYN1-CNH were then constructed through PCR-based subcloning into pAAV-CAG-GFP, pAAV-hGFAP-GFP and pAAV-hSYN1-GFP, respectively. ..

    Article Title: The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
    Article Snippet: .. The following plasmids were obtained from Addgene (Watertown, MA, USA): pAd-deltaF6 (#112867), pUCmini-iCAP-PHP.eB (#103005), pAAV2/5 (#104964), pAAV2/9 (#112865), and pAAV-CAG-GFP (#37825). pAAV-hGFAP-GFP was previously described (Wang et al., 2021). pAAV-hSYN1-GFP was made by replacing the hGFAP promoter with the hSYN1 promoter (from Addgene #50457). pAAV-CAG-GFP-CNH , pAAV-CAG-BioID2-CNH , pAAV-hGFAP-CNH , and pAAV-hSYN1-CNH were then constructed through PCR-based subcloning into pAAV-CAG-GFP , pAAV-hGFAP-GFP and pAAV-hSYN1-GFP , respectively. ..

    Subcloning:

    Article Title: The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
    Article Snippet: .. The following plasmids were obtained from Addgene (Watertown, MA, USA): pAd-deltaF6 (#112867), pUCmini-iCAPPHP.eB (#103005), pAAV2/5 (#104964), pAAV2/9 (#112865), and pAAV-CAG-GFP (#37825). pAAV-hGFAP-GFP was previously described (Wang et al., 2021). pAAV-hSYN1-GFP was made by replacing the hGFAP promoter with the hSYN1 promoter (from Addgene #50457). pAAV-CAG-GFP-CNH, pAAV-CAGBioID2-CNH, pAAV-hGFAP-CNH, and pAAV-hSYN1-CNH were then constructed through PCR-based subcloning into pAAV-CAG-GFP, pAAV-hGFAP-GFP and pAAV-hSYN1-GFP, respectively. ..

    Article Title: The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
    Article Snippet: .. The following plasmids were obtained from Addgene (Watertown, MA, USA): pAd-deltaF6 (#112867), pUCmini-iCAP-PHP.eB (#103005), pAAV2/5 (#104964), pAAV2/9 (#112865), and pAAV-CAG-GFP (#37825). pAAV-hGFAP-GFP was previously described (Wang et al., 2021). pAAV-hSYN1-GFP was made by replacing the hGFAP promoter with the hSYN1 promoter (from Addgene #50457). pAAV-CAG-GFP-CNH , pAAV-CAG-BioID2-CNH , pAAV-hGFAP-CNH , and pAAV-hSYN1-CNH were then constructed through PCR-based subcloning into pAAV-CAG-GFP , pAAV-hGFAP-GFP and pAAV-hSYN1-GFP , respectively. ..



    Similar Products

    93
    Addgene inc human synapsin1 promoter
    Human Synapsin1 Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hsyn1+promoter/pAAV%2EhSyn1%2ETwitch2B%2EWPRE%2ESV40+(Plasmid+%23100040)/bio_rxiv__2025__11__24__690198-110-25-29
    Average 93 stars, based on 1 article reviews
    human synapsin1 promoter - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Addgene inc human synapsin1 promoter hsyn1p
    MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the <t>synapsin1-driven</t> GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).
    Human Synapsin1 Promoter Hsyn1p, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hsyn1+promoter/pAAV-hSyn1-mRuby2-GSG-P2A-GCaMP6f-WPRE-pA+(Plasmid+%2350943)/pmc12590003-454-23-27
    Average 93 stars, based on 1 article reviews
    human synapsin1 promoter hsyn1p - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    96
    Addgene inc hsyn1 promoter
    CNH in neurons exerts neuroprotection. (A) Experimental design to examine CNH function in astrocytes. Gene expression is controlled by the astrocyte-specific human GFAP ( hGFAP ) promoter. (B) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (C) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 5 mice per group; P = 0.1767). (D) Representative images showing AT8 surrounding the cortical lesion. Scale bar: 50 µm. (E) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 5 mice per group; P = 0.7153). (F) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (G) Quantification of GFAP + scar volumes (mean ± SEM; n = 5 mice per group; P = 0.7448). (H) Representative images of brain sections for lesion quantification (yellow outlined). Scale bar: 1 mm. (I) Quantification of cortical volumes post injury (mean ± SEM; n = 5 mice per group; P = 0.9039). (J) Experimental design to examine CNH function in neurons. Gene expression is controlled by the neuron-specific human SYN1 ( <t>hSYN1</t> ) promoter. (K) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (L) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 6 mice per group; P = 0.0007). (M) Representative images showing immunostaining of AT8 surrounding the cortical lesion. Scale bar: 50 µm. (N) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 6 mice per group; P = 0.0152). (O) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (P) Quantification of GFAP + scar volumes (mean ± SEM; n = 6 mice per group; P = 0.0042). (Q) Representative images of brain sections for lesion quantifications (yellow outlined). Scale bar: 1 mm. (R) Quantification of cortical volumes post injury (mean ± SEM; n = 6 mice per group; P = 0.0227). AAV: Adeno-associated virus; Br: bregma; CCI: controlled cortical impact; CNH: Citron homology domain; dpi: days post-injury; GFAP: glial acidic fibrillary acidic protein; IHC: immunohistochemistry.
    Hsyn1 Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hsyn1+promoter/pAAV-hSyn-DIO-EGFP+(Plasmid+%2350457)/pmc11881717-32-39-42
    Average 96 stars, based on 1 article reviews
    hsyn1 promoter - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    Addgene inc synapsin 1 promoter
    CNH in neurons exerts neuroprotection. (A) Experimental design to examine CNH function in astrocytes. Gene expression is controlled by the astrocyte-specific human GFAP ( hGFAP ) promoter. (B) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (C) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 5 mice per group; P = 0.1767). (D) Representative images showing AT8 surrounding the cortical lesion. Scale bar: 50 µm. (E) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 5 mice per group; P = 0.7153). (F) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (G) Quantification of GFAP + scar volumes (mean ± SEM; n = 5 mice per group; P = 0.7448). (H) Representative images of brain sections for lesion quantification (yellow outlined). Scale bar: 1 mm. (I) Quantification of cortical volumes post injury (mean ± SEM; n = 5 mice per group; P = 0.9039). (J) Experimental design to examine CNH function in neurons. Gene expression is controlled by the neuron-specific human SYN1 ( <t>hSYN1</t> ) promoter. (K) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (L) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 6 mice per group; P = 0.0007). (M) Representative images showing immunostaining of AT8 surrounding the cortical lesion. Scale bar: 50 µm. (N) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 6 mice per group; P = 0.0152). (O) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (P) Quantification of GFAP + scar volumes (mean ± SEM; n = 6 mice per group; P = 0.0042). (Q) Representative images of brain sections for lesion quantifications (yellow outlined). Scale bar: 1 mm. (R) Quantification of cortical volumes post injury (mean ± SEM; n = 6 mice per group; P = 0.0227). AAV: Adeno-associated virus; Br: bregma; CCI: controlled cortical impact; CNH: Citron homology domain; dpi: days post-injury; GFAP: glial acidic fibrillary acidic protein; IHC: immunohistochemistry.
    Synapsin 1 Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hsyn1+promoter/pAAV-hSyn1-mRuby2-GSG-P2A-GCaMP6s-WPRE-pA+(Plasmid+%2350942)/bio_rxiv__2023__11__25__568638-149-32-39
    Average 94 stars, based on 1 article reviews
    synapsin 1 promoter - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Addgene inc synapsin promoter
    CNH in neurons exerts neuroprotection. (A) Experimental design to examine CNH function in astrocytes. Gene expression is controlled by the astrocyte-specific human GFAP ( hGFAP ) promoter. (B) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (C) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 5 mice per group; P = 0.1767). (D) Representative images showing AT8 surrounding the cortical lesion. Scale bar: 50 µm. (E) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 5 mice per group; P = 0.7153). (F) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (G) Quantification of GFAP + scar volumes (mean ± SEM; n = 5 mice per group; P = 0.7448). (H) Representative images of brain sections for lesion quantification (yellow outlined). Scale bar: 1 mm. (I) Quantification of cortical volumes post injury (mean ± SEM; n = 5 mice per group; P = 0.9039). (J) Experimental design to examine CNH function in neurons. Gene expression is controlled by the neuron-specific human SYN1 ( <t>hSYN1</t> ) promoter. (K) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (L) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 6 mice per group; P = 0.0007). (M) Representative images showing immunostaining of AT8 surrounding the cortical lesion. Scale bar: 50 µm. (N) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 6 mice per group; P = 0.0152). (O) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (P) Quantification of GFAP + scar volumes (mean ± SEM; n = 6 mice per group; P = 0.0042). (Q) Representative images of brain sections for lesion quantifications (yellow outlined). Scale bar: 1 mm. (R) Quantification of cortical volumes post injury (mean ± SEM; n = 6 mice per group; P = 0.0227). AAV: Adeno-associated virus; Br: bregma; CCI: controlled cortical impact; CNH: Citron homology domain; dpi: days post-injury; GFAP: glial acidic fibrillary acidic protein; IHC: immunohistochemistry.
    Synapsin Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hsyn1+promoter/pAAV-hSyn1-mRuby2-GSG-P2A-GCaMP6s-WPRE-pA+(Plasmid+%2350942)/pm36451089-54-18-25
    Average 94 stars, based on 1 article reviews
    synapsin promoter - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Addgene inc human synapsin promoter
    CNH in neurons exerts neuroprotection. (A) Experimental design to examine CNH function in astrocytes. Gene expression is controlled by the astrocyte-specific human GFAP ( hGFAP ) promoter. (B) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (C) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 5 mice per group; P = 0.1767). (D) Representative images showing AT8 surrounding the cortical lesion. Scale bar: 50 µm. (E) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 5 mice per group; P = 0.7153). (F) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (G) Quantification of GFAP + scar volumes (mean ± SEM; n = 5 mice per group; P = 0.7448). (H) Representative images of brain sections for lesion quantification (yellow outlined). Scale bar: 1 mm. (I) Quantification of cortical volumes post injury (mean ± SEM; n = 5 mice per group; P = 0.9039). (J) Experimental design to examine CNH function in neurons. Gene expression is controlled by the neuron-specific human SYN1 ( <t>hSYN1</t> ) promoter. (K) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (L) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 6 mice per group; P = 0.0007). (M) Representative images showing immunostaining of AT8 surrounding the cortical lesion. Scale bar: 50 µm. (N) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 6 mice per group; P = 0.0152). (O) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (P) Quantification of GFAP + scar volumes (mean ± SEM; n = 6 mice per group; P = 0.0042). (Q) Representative images of brain sections for lesion quantifications (yellow outlined). Scale bar: 1 mm. (R) Quantification of cortical volumes post injury (mean ± SEM; n = 6 mice per group; P = 0.0227). AAV: Adeno-associated virus; Br: bregma; CCI: controlled cortical impact; CNH: Citron homology domain; dpi: days post-injury; GFAP: glial acidic fibrillary acidic protein; IHC: immunohistochemistry.
    Human Synapsin Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hsyn1+promoter/pAAV-hSyn1-mRuby2-GSG-P2A-GCaMP6s-WPRE-pA+(Plasmid+%2350942)/pm36114512-68-17-24
    Average 94 stars, based on 1 article reviews
    human synapsin promoter - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the synapsin1-driven GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).

    Journal: iScience

    Article Title: TAOK2 controls synaptic plasticity and anxiety via ERK and calcium signaling

    doi: 10.1016/j.isci.2025.113712

    Figure Lengend Snippet: MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the synapsin1-driven GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).

    Article Snippet: On DIV6, half the medium was changed and the neurons were infected with AAVs for expression of mRuby2-P2A-GCaMP6f under the control of the human synapsin1 promoter (hSyn1p) (Addgene #50943) at an MOI of 1000.

    Techniques: Luciferase, Activity Assay, In Vitro, Imaging, Control, Infection, Expressing, Western Blot

    CNH in neurons exerts neuroprotection. (A) Experimental design to examine CNH function in astrocytes. Gene expression is controlled by the astrocyte-specific human GFAP ( hGFAP ) promoter. (B) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (C) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 5 mice per group; P = 0.1767). (D) Representative images showing AT8 surrounding the cortical lesion. Scale bar: 50 µm. (E) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 5 mice per group; P = 0.7153). (F) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (G) Quantification of GFAP + scar volumes (mean ± SEM; n = 5 mice per group; P = 0.7448). (H) Representative images of brain sections for lesion quantification (yellow outlined). Scale bar: 1 mm. (I) Quantification of cortical volumes post injury (mean ± SEM; n = 5 mice per group; P = 0.9039). (J) Experimental design to examine CNH function in neurons. Gene expression is controlled by the neuron-specific human SYN1 ( hSYN1 ) promoter. (K) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (L) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 6 mice per group; P = 0.0007). (M) Representative images showing immunostaining of AT8 surrounding the cortical lesion. Scale bar: 50 µm. (N) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 6 mice per group; P = 0.0152). (O) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (P) Quantification of GFAP + scar volumes (mean ± SEM; n = 6 mice per group; P = 0.0042). (Q) Representative images of brain sections for lesion quantifications (yellow outlined). Scale bar: 1 mm. (R) Quantification of cortical volumes post injury (mean ± SEM; n = 6 mice per group; P = 0.0227). AAV: Adeno-associated virus; Br: bregma; CCI: controlled cortical impact; CNH: Citron homology domain; dpi: days post-injury; GFAP: glial acidic fibrillary acidic protein; IHC: immunohistochemistry.

    Journal: Neural Regeneration Research

    Article Title: The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury

    doi: 10.4103/NRR.NRR-D-24-00113

    Figure Lengend Snippet: CNH in neurons exerts neuroprotection. (A) Experimental design to examine CNH function in astrocytes. Gene expression is controlled by the astrocyte-specific human GFAP ( hGFAP ) promoter. (B) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (C) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 5 mice per group; P = 0.1767). (D) Representative images showing AT8 surrounding the cortical lesion. Scale bar: 50 µm. (E) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 5 mice per group; P = 0.7153). (F) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (G) Quantification of GFAP + scar volumes (mean ± SEM; n = 5 mice per group; P = 0.7448). (H) Representative images of brain sections for lesion quantification (yellow outlined). Scale bar: 1 mm. (I) Quantification of cortical volumes post injury (mean ± SEM; n = 5 mice per group; P = 0.9039). (J) Experimental design to examine CNH function in neurons. Gene expression is controlled by the neuron-specific human SYN1 ( hSYN1 ) promoter. (K) Representative images showing GFAP + cells surrounding the cortical lesion. Scale bar: 50 µm. (L) Quantification of fluorescence intensity of GFAP (mean ± SEM; n = 6 mice per group; P = 0.0007). (M) Representative images showing immunostaining of AT8 surrounding the cortical lesion. Scale bar: 50 µm. (N) Quantification of AT8 fluorescence intensity (mean ± SEM; n = 6 mice per group; P = 0.0152). (O) Representative images of brain sections showing GFAP + glial scar (yellow outlined). Scale bar: 1 mm. (P) Quantification of GFAP + scar volumes (mean ± SEM; n = 6 mice per group; P = 0.0042). (Q) Representative images of brain sections for lesion quantifications (yellow outlined). Scale bar: 1 mm. (R) Quantification of cortical volumes post injury (mean ± SEM; n = 6 mice per group; P = 0.0227). AAV: Adeno-associated virus; Br: bregma; CCI: controlled cortical impact; CNH: Citron homology domain; dpi: days post-injury; GFAP: glial acidic fibrillary acidic protein; IHC: immunohistochemistry.

    Article Snippet: The following plasmids were obtained from Addgene (Watertown, MA, USA): pAd-deltaF6 (#112867), pUCmini-iCAP-PHP.eB (#103005), pAAV2/5 (#104964), pAAV2/9 (#112865), and pAAV-CAG-GFP (#37825). pAAV-hGFAP-GFP was previously described (Wang et al., 2021). pAAV-hSYN1-GFP was made by replacing the hGFAP promoter with the hSYN1 promoter (from Addgene #50457). pAAV-CAG-GFP-CNH , pAAV-CAG-BioID2-CNH , pAAV-hGFAP-CNH , and pAAV-hSYN1-CNH were then constructed through PCR-based subcloning into pAAV-CAG-GFP , pAAV-hGFAP-GFP and pAAV-hSYN1-GFP , respectively.

    Techniques: Gene Expression, Fluorescence, Immunostaining, Virus, Immunohistochemistry